A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer

BACKGROUND/AIMS: No standard chemotherapy has been established for advanced gallbladder cancer. The authors studied the activity and tolerability of a gemcitabine and oxaliplatin (GEMOX) combination in unresectable gallbladder cancer (GBC). METHODS: Adult patients with pathologically confirmed unres...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Sang Myung, Lee, Sang Hyub, Yoo, Ji Won, Yang, Ki Young, Seo, Jung Gyun, Park, Joo Kyung, Hwang, Jin-Hyeok, Lee, Woo Jin, Ryu, Ji Kon, Kim, Yong-Tae, Yoon, Yong Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Pancreatobiliary Association; Korean Society of Gastrointestinal Cancer 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782675/
https://www.ncbi.nlm.nih.gov/pubmed/24073318
http://dx.doi.org/10.5009/gnl.2013.7.5.594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782675/
https://www.ncbi.nlm.nih.gov/pubmed/24073318
http://dx.doi.org/10.5009/gnl.2013.7.5.594

Ejemplares similares